Larson Financial Group’s Definium Therapeutics DFTX Stock Holding History

Larson Financial Group’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.1K	Hold	535	–	–	﹤0.01%	2248
2025 Q4	$7.16K	Buy	+535	New	+$6.62K	﹤0.01%	2302
2025 Q3	–	Sell	-2,932	Closed	-$19K	–	3573
2025 Q2	$19K	Hold	2,932	–	–	﹤0.01%	1512
2025 Q1	$17.2K	Buy	+2,932	New	+$21K	﹤0.01%	1424
2022 Q2	–	Sell	-14	Closed	–	–	1259
2022 Q1	$0	Hold	14	–	–	﹤0.01%	1125
2021 Q4	$0	Hold	14	–	–	﹤0.01%	1140
2021 Q3	$1K	Hold	14	–	–	﹤0.01%	839
2021 Q2	$1K	Buy	+14	New	+$735	﹤0.01%	780

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Larson Financial Group's DFTX Position: Q1 2026 in Review

Larson Financial Group held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 535 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

Larson Financial Group first reported a position in DFTX in Q2 2021 and has held it in 8 quarters since. The position peaked at $19K in Q2 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Larson Financial Group held 535 shares of Definium Therapeutics worth $10.1K as of Q1 2026.
Larson Financial Group left its Definium Therapeutics share count unchanged in Q1 2026.
Definium Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2248 holding.
Larson Financial Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 8 quarters since.
Larson Financial Group's Definium Therapeutics position peaked at $19K in Q2 2025.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.